Literature DB >> 26852901

Margins for cervical and vulvar cancer.

Namita Khanna1,2, Lisa A Rauh2, Mark P Lachiewicz2, Ira R Horowitz1,2.   

Abstract

Surgery is the primary treatment for vulvar cancer as well as early-stage carcinoma of the cervix. This article reviews the significance of margin status after surgery on overall survival, need for further surgical intervention, and role for possible adjuvant therapy. It summarizes the abundant literature on margin status in vulvar cancer and highlights the need for further investigation on the prognostic significance of margins in cervical cancer. In addition, it reviews other important operative considerations.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  cervical neoplasms; vulvar neoplasms

Mesh:

Year:  2016        PMID: 26852901     DOI: 10.1002/jso.24108

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  8 in total

1.  LncRNA SNHG6 enhances the radioresistance and promotes the growth of cervical cancer cells by sponging miR-485-3p.

Authors:  Jin Liu; Xiaojiao Liu; Rong Li
Journal:  Cancer Cell Int       Date:  2020-08-31       Impact factor: 5.722

2.  The intelligent knife (iKnife) and its intraoperative diagnostic advantage for the treatment of cervical disease.

Authors:  Menelaos Tzafetas; Anita Mitra; Maria Paraskevaidi; Zsolt Bodai; Ilkka Kalliala; Sarah Bowden; Konstantinos Lathouras; Francesca Rosini; Marcell Szasz; Adele Savage; Julia Balog; James McKenzie; Deirdre Lyons; Phillip Bennett; David MacIntyre; Sadaf Ghaem-Maghami; Zoltan Takats; Maria Kyrgiou
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-16       Impact factor: 11.205

3.  MALDI Mass Spectrometry Imaging Reveals Decreased CK5 Levels in Vulvar Squamous Cell Carcinomas Compared to the Precursor Lesion Differentiated Vulvar Intraepithelial Neoplasia.

Authors:  Chao Zhang; Georgia Arentz; Lyron Winderbaum; Noor A Lokman; Manuela Klingler-Hoffmann; Parul Mittal; Christopher Carter; Martin K Oehler; Peter Hoffmann
Journal:  Int J Mol Sci       Date:  2016-07-08       Impact factor: 5.923

4.  Impact of different therapies on the survival of patients with stage I-IIA cervical cancer with intermediate risk factors.

Authors:  Jichan Nie; Qinjiao Wu; Anqi Yan; Zhiyong Wu
Journal:  Ann Transl Med       Date:  2021-01

Review 5.  Electroporation and Electrochemotherapy in Gynecological and Breast Cancer Treatment.

Authors:  Zofia Łapińska; Urszula Szwedowicz; Anna Choromańska; Jolanta Saczko
Journal:  Molecules       Date:  2022-04-12       Impact factor: 4.927

6.  SUCCOR Risk: Design and Validation of a Recurrence Prediction Index for Early-Stage Cervical Cancer.

Authors:  Nabil Manzour; Luis Chiva; Enrique Chacón; Nerea Martin-Calvo; Felix Boria; José A Minguez; Juan L Alcazar
Journal:  Ann Surg Oncol       Date:  2022-04-16       Impact factor: 4.339

7.  Cancer of the vulva: 2021 update.

Authors:  Alexander B Olawaiye; Mauricio A Cuello; Linda J Rogers
Journal:  Int J Gynaecol Obstet       Date:  2021-10       Impact factor: 4.447

8.  Engineered Nickel Oxide Nanoparticle Causes Substantial Physicochemical Perturbation in Plants.

Authors:  Indrani Manna; Maumita Bandyopadhyay
Journal:  Front Chem       Date:  2017-11-08       Impact factor: 5.221

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.